AstraZeneca Wins Seroquel Suit, But Court Punts Warning Issue

Law360, New York (July 11, 2012, 3:43 PM EDT) -- A Washington federal judge ruled Monday that AstraZeneca LP was not responsible for warning a Seroquel user that the antipsychotic could cause a neurological disorder, though he declined to address whether overpromotion of a drug imposes a duty to warn on its manufacturer.

Plaintiff Kay Patteson had argued to U.S. District Judge James E. Boasberg that the learned intermediary doctrine, which shields drugmakers from failure-to-warn claims if they apprised a plaintiff's physician of the product's risks, should not apply to AstraZeneca. Patteson relied on the so-called...
To view the full article, register now.